Mathias Freund

10.3k total citations · 2 hit papers
178 papers, 6.5k citations indexed

About

Mathias Freund is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Mathias Freund has authored 178 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Hematology, 50 papers in Oncology and 38 papers in Genetics. Recurrent topics in Mathias Freund's work include Acute Myeloid Leukemia Research (44 papers), Hematopoietic Stem Cell Transplantation (44 papers) and Lymphoma Diagnosis and Treatment (26 papers). Mathias Freund is often cited by papers focused on Acute Myeloid Leukemia Research (44 papers), Hematopoietic Stem Cell Transplantation (44 papers) and Lymphoma Diagnosis and Treatment (26 papers). Mathias Freund collaborates with scholars based in Germany, United States and Austria. Mathias Freund's co-authors include Christoph Nienaber, Michael Petzsch, Hans‐Dieter Kleine, C. Schümichen, Christof Stamm, Gustav Steinhoff, Bernd Westphal, Arnold Ganser, H. Diedrich and Gerhard Heil and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Mathias Freund

175 papers receiving 6.3k citations

Hit Papers

Autologous bone-marrow st... 1988 2026 2000 2013 2003 1988 250 500 750 1000

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mathias Freund 2.3k 1.9k 1.6k 1.6k 1.4k 178 6.5k
Werner Linkesch 1.9k 0.8× 1.6k 0.9× 1.6k 0.9× 1.6k 1.0× 501 0.4× 184 5.6k
Bernd Hertenstein 3.6k 1.6× 2.7k 1.4× 1.6k 1.0× 1.7k 1.1× 909 0.6× 154 8.7k
Giorgio La Nasa 2.3k 1.0× 2.7k 1.4× 1.3k 0.8× 1.8k 1.1× 428 0.3× 275 6.7k
Steven M. Devine 6.1k 2.7× 3.1k 1.6× 3.4k 2.1× 2.2k 1.4× 1.3k 0.9× 318 11.0k
Josè Antonio Pérez-Simón 3.9k 1.7× 1.6k 0.9× 1.6k 1.0× 1.8k 1.1× 687 0.5× 236 6.5k
Mats Remberger 5.9k 2.6× 3.0k 1.6× 2.4k 1.5× 953 0.6× 1.2k 0.8× 243 10.0k
Peter A. McSweeney 3.9k 1.7× 1.0k 0.5× 1.6k 1.0× 845 0.5× 821 0.6× 143 6.3k
Mark L. Bernstein 785 0.3× 677 0.4× 1.8k 1.1× 2.2k 1.4× 667 0.5× 184 7.5k
Sally E. Kinsey 1.5k 0.6× 1.2k 0.6× 982 0.6× 876 0.6× 2.0k 1.4× 116 5.1k
Jill Hows 7.2k 3.2× 2.2k 1.2× 2.2k 1.3× 970 0.6× 1.4k 1.0× 101 9.8k

Countries citing papers authored by Mathias Freund

Since Specialization
Citations

This map shows the geographic impact of Mathias Freund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Freund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Freund more than expected).

Fields of papers citing papers by Mathias Freund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Freund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Freund. The network helps show where Mathias Freund may publish in the future.

Co-authorship network of co-authors of Mathias Freund

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Freund. A scholar is included among the top collaborators of Mathias Freund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Freund. Mathias Freund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Xinchao, Hua Pang, Xun Xu, et al.. (2012). Streptamer versus tetramer-based selection of functional cytomegalovirus-specific T cells. Journal of the Formosan Medical Association. 112(6). 338–345. 10 indexed citations
3.
Hilgendorf, Inken, Mathias Freund, Wolfgang Jilg, et al.. (2011). Vaccination of allogeneic haematopoietic stem cell transplant recipients: Report from the International Consensus Conference on Clinical Practice in chronic GVHD. Vaccine. 29(16). 2825–2833. 65 indexed citations
4.
Glaß, B., Marita Ziepert, Marcel Reiser, et al.. (2010). High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma. Annals of Oncology. 21(11). 2255–2261. 24 indexed citations
5.
Wang, Xinchao, Anita Schmitt, Baoan Chen, et al.. (2010). Streptamer-based selection of WT1-specific CD8+ T cells for specific donor lymphocyte infusions. Experimental Hematology. 38(11). 1066–1073. 18 indexed citations
8.
Dreyling, M., et al.. (2006). Results of a national consensus workshop: therapeutic algorithm in patients with follicular lymphoma—role of radioimmunotherapy. Annals of Hematology. 86(2). 81–87. 27 indexed citations
9.
Steiner, Beat, et al.. (2005). Kieferosteonekrosen unter Bisphosphonattherapie: Diagnostik und Therapie. DMW - Deutsche Medizinische Wochenschrift. 130(38). 2142–2145. 1 indexed citations
10.
Kahl, Christoph, Daniel Wolff, Beate Steiner, et al.. (2002). Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation. Annals of Hematology. 81(11). 646–650. 26 indexed citations
11.
Wolff, Daniel, Frank Reichenberger, Beate Steiner, et al.. (2002). Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease. Bone Marrow Transplantation. 29(4). 357–360. 27 indexed citations
12.
Heil, Gerhard, P.S. Mitrou, D. Hoelzer, et al.. (1995). High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia Long-term follow-up of a prospective multicenter trial. Annals of Hematology. 71(5). 219–225. 1 indexed citations
13.
Hanauske, Axel‐R., et al.. (1992). Effects of Cytokines on Clonogenic Growth of Primary Renal Cancer Cells: An in vitro Phase II Study. Oncology Research and Treatment. 15(2). 147–150. 3 indexed citations
14.
Steinke, B., C. Manegold, Mathias Freund, et al.. (1992). G-CSF for Treatment Intensification in High-Grade Malignant Non-Hodgkin’s Lymphomas. Oncology Research and Treatment. 15(1). 46–50. 3 indexed citations
15.
Kurrle, E., Gerhard Ehninger, Mathias Freund, et al.. (1988). A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia. Annals of Hematology. 56(5). 233–236. 9 indexed citations
16.
Kurrle, E., Gerhard Ehninger, Mathias Freund, et al.. (1986). Age Adapted Induction and Intensified Consolidation Therapy in Acute Myelogenous Leukemia. Oncology Research and Treatment. 9(3). 141–143. 3 indexed citations
17.
Kovács, Gábor, Mathias Freund, & A. Georgii. (1985). Trisomy 1q and Deletion of 11q in Acute Myelofibrosis. Acta Haematologica. 73(3). 179–180. 3 indexed citations
18.
Freund, Mathias, et al.. (1985). Treatment of Acute Myelocytic Leukemia with a Daunorubicin-Cytarabine-6 Thioguanine Regimen without Maintenance Therapy. Oncology Research and Treatment. 8(3). 150–152. 2 indexed citations
19.
Luciani, J. M., et al.. (1978). The meiotic behavior of triploidy in a human 69,XXX fetus. Cytogenetic and Genome Research. 20(1-6). 226–231. 2 indexed citations
20.
Lorenz, W, et al.. (1975). [Plasma histamine levels in man following infusion of hydroxyethyl starch: a contribution to the question of allergic or anaphylactoid reactions following administration of a new plasma substitute (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 24(5). 228–30. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026